GVA vs SYRE

Comparison between Granite Construction Inc (GVA, Company) and Spyre Therapeutics Inc (SYRE, Company).

GVA is from the Industrials sector, while SYRE is from the Healthcare sector.

5-Year PerformanceGVA has outperformed SYRE, delivering a return of +30.0% compared to -13.3%

GVA vs SYRE - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	GVA(COMPANY)	SYRE(COMPANY)
Market Cap	$5.94B	$5.92B
Max Drawdown	86.24%	99.11%
Sharpe Ratio	1.66	2.43
5Y Beta	0.86	1.75
Industry	Engineering & Construction	Biotechnology
P/E Ratio	32.06	-30.42
Forward P/E	20.58	N/A
PEG Ratio	0.65	N/A
Dividend Yield	0.38%	N/A
5Y Dividends CAGR	4.56%	N/A
5Y EPS CAGR	N/A	-2.15%
Debt to Equity	120.24%	0.00%
Free Cash Flow Yield	5.09%	-3.14%
P/S Ratio	1.31	650.22
P/B Ratio	5.75	12.66

Market Cap

Winner

GVA

$5.94B

SYRE

$5.92B

Max Drawdown

Winner

GVA

86.24%

SYRE

99.11%

Sharpe Ratio

GVA

1.66

Winner

SYRE

2.43

5Y Beta

Winner

GVA

0.86

SYRE

1.75

Industry

GVA

Engineering & Construction

SYRE

Biotechnology

P/E Ratio

GVA

32.06

Winner

SYRE

-30.42

Forward P/E

GVA

20.58

SYRE

N/A

PEG Ratio

GVA

0.65

SYRE

N/A

Dividend Yield

GVA

0.38%

SYRE

N/A

5Y Dividends CAGR

GVA

4.56%

SYRE

N/A

5Y EPS CAGR

GVA

N/A

SYRE

-2.15%

Debt to Equity

GVA

120.24%

Winner

SYRE

0.00%

Free Cash Flow Yield

Winner

GVA

5.09%

SYRE

-3.14%

P/S Ratio

Winner

GVA

1.31

SYRE

650.22

P/B Ratio

Winner

GVA

5.75

SYRE

12.66

GVA vs SYRE - Historical Returns

Returns include dividend reinvestment.

Period	GVA	SYRE
1 month	+0.13%	+7.66%
3 months	+13.81%	+99.93%
6 months	+22.45%	+140.30%
1 year	+57.87%	+356.18%
5 years(CAGR)	+30.00%	-13.30%
10 years(CAGR)	+13.90%	-6.27%
Max(CAGR)	+10.94%	-10.30%

GVA

+0.13%

Winner

SYRE

+7.66%

GVA

+13.81%

Winner

SYRE

+99.93%

GVA

+22.45%

Winner

SYRE

+140.30%

GVA

+57.87%

Winner

SYRE

+356.18%

5Y(CAGR)

Winner

GVA

+30.00%

SYRE

-13.30%

10Y(CAGR)

Winner

GVA

+13.90%

SYRE

-6.27%

Max(CAGR)

Winner

GVA

+10.94%

SYRE

-10.30%

GVA vs SYRE - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	GVA	SYRE
2026	+18.61%	+164.19%
2025	+31.91%	+37.36%
2024	+75.44%	+8.79%
2023	+47.00%	+104.27%
2022	-8.92%	-90.57%
2021	+47.29%	-44.51%
2020	-0.40%	+1.55%
2019	-30.47%	-4.98%
2018	-36.37%	+39.22%
2017	+16.08%	+18.38%
2016	+33.59%	-55.48%
2015	+17.09%	N/A
2014	+13.24%	N/A
2013	+2.04%	N/A
2012	+40.60%	N/A
2011	-13.98%	N/A
2010	-18.14%	N/A
2009	-23.70%	N/A
2008	+23.30%	N/A
2007	-27.78%	N/A
2006	+36.91%	N/A
2005	+39.27%	N/A
2004	+13.51%	N/A
2003	+43.24%	N/A
2002	-35.38%	N/A
2001	+26.31%	N/A
2000	+66.79%	N/A
1999	-5.36%	N/A

GVA vs SYRE Drawdown Comparison

The maximum drawdown for GVA was -84.73%, occurring on Mar 17, 2020. Recovery took 1580 trading sessions.

The maximum drawdown for SYRE was -99.11%, occurring on Jun 21, 2023. This drawdown has not yet recovered.

The current GVA drawdown is -1.77%. The current SYRE drawdown is -73.05%.

Rank	GVA	SYRE
#1	-84.73% Jan 29, 2018 - May 9, 2024	-99.11% Apr 8, 2016 - Jun 21, 2023
#2	-75.06% Jul 13, 2007 - Oct 27, 2017	N/A
#3	-53.23% May 14, 2001 - Jul 1, 2005	N/A
#4	-29.06% Dec 4, 2024 - Aug 7, 2025	N/A
#5	-26.75% Apr 21, 2006 - Aug 22, 2006	N/A
#6	-25.19% May 11, 2000 - Nov 17, 2000	N/A
#7	-24.25% Oct 19, 2006 - Apr 27, 2007	N/A
#8	-16.54% Nov 15, 1999 - Jan 7, 2000	N/A
#9	-16.01% Oct 3, 2005 - Nov 22, 2005	N/A
#10	-15.69% Mar 21, 2000 - May 11, 2000	N/A
#11	-14.69% Feb 24, 2026 - Apr 30, 2026	N/A
#12	-12.42% Mar 2, 2001 - Apr 10, 2001	N/A
#13	-11.45% Jan 16, 2001 - Feb 9, 2001	N/A
#14	-11.39% Aug 13, 2025 - Dec 10, 2025	N/A
#15	-10.83% May 13, 2026 - May 21, 2026	N/A

Correlation

Correlation between GVA and SYRE is -0.44 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.44

-101